• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Liver-specific therapies for metastases of neuroendocrine pancreatic tumors.针对胰腺神经内分泌肿瘤转移的肝脏特异性疗法。
World J Hepatol. 2010 Oct 27;2(10):367-73. doi: 10.4254/wjh.v2.i10.367.
2
Metastases of pancreatic neuroendocrine tumor to the liver as extremely rare indication for liver transplantation in children. Case report and review of the literature.胰腺神经内分泌肿瘤肝转移作为儿童肝移植的极罕见适应证。病例报告及文献复习。
Clin Res Hepatol Gastroenterol. 2016 Sep;40(4):e33-7. doi: 10.1016/j.clinre.2015.12.001. Epub 2016 Feb 2.
3
[Controversies and prospects for surgical treatment of pancreatic neuroendocrine neoplasms with liver metastases].
Zhonghua Wai Ke Za Zhi. 2023 Oct 1;61(10):839-844. doi: 10.3760/cma.j.cn112139-20230319-00114.
4
The prognostic impact of primary tumor resection in pancreatic neuroendocrine tumors with synchronous multifocal liver metastases.原发性肿瘤切除对伴有同步多灶性肝转移的胰腺神经内分泌肿瘤的预后影响。
Pancreatology. 2018 Jul;18(5):608-614. doi: 10.1016/j.pan.2018.04.014. Epub 2018 Apr 30.
5
Liver transplantation in patients with liver metastases from neuroendocrine tumors: A systematic review.神经内分泌肿瘤肝转移患者的肝移植：一项系统综述。
Surgery. 2017 Sep;162(3):525-536. doi: 10.1016/j.surg.2017.05.006. Epub 2017 Jun 16.
6
[Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies].[胃肠胰系统神经内分泌肿瘤的肝转移——治疗策略]
Zentralbl Chir. 2009 Sep;134(5):410-7. doi: 10.1055/s-0029-1224607. Epub 2009 Sep 15.
7
Systemic treatment of neuroendocrine tumors with hepatic metastases.伴有肝转移的神经内分泌肿瘤的全身治疗
Turk J Gastroenterol. 2012;23(5):427-37. doi: 10.4318/tjg.2012.0552.
8
Therapeutic strategies for neuroendocrine liver metastases.神经内分泌性肝转移瘤的治疗策略
Cancer. 2015 Apr 15;121(8):1172-86. doi: 10.1002/cncr.28760. Epub 2014 Oct 1.
9
Surgical approaches for liver metastases in carcinoid tumors.类癌肿瘤肝转移的手术治疗方法。
Gland Surg. 2015 Oct;4(5):442-6. doi: 10.3978/j.issn.2227-684X.2015.04.10.
10
Hepatic surgery for metastases from neuroendocrine tumors.神经内分泌肿瘤肝转移的肝手术治疗
Surg Oncol Clin N Am. 2003 Jan;12(1):231-42. doi: 10.1016/s1055-3207(02)00076-5.

引用本文的文献

1
Neuroendocrine liver metastases: contributions of endoscopy and surgery to primary tumor search.神经内分泌肝转移：内镜和手术对原发病灶探查的贡献。
World J Gastroenterol. 2012 Mar 14;18(10):1009-14. doi: 10.3748/wjg.v18.i10.1009.
2
Surgical treatment of neuroendocrine liver metastases.神经内分泌肝转移瘤的外科治疗
Int J Hepatol. 2012;2012:146590. doi: 10.1155/2012/146590. Epub 2012 Jan 26.
3
ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes.ENETS 消化神经内分泌肿瘤患者管理共识指南：功能性胰腺内分泌肿瘤综合征
Neuroendocrinology. 2012;95(2):98-119. doi: 10.1159/000335591. Epub 2012 Feb 15.
4
Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.预测神经内分泌肝脏转移经放射栓塞（TheraSphere®）治疗的反应的因素。
HPB (Oxford). 2012 Jan;14(1):60-6. doi: 10.1111/j.1477-2574.2011.00405.x. Epub 2011 Nov 14.
5
Multimodal liver-directed management of neuroendocrine hepatic metastases.神经内分泌肝转移瘤的多模式肝脏定向治疗
Int J Hepatol. 2011;2011:452343. doi: 10.4061/2011/452343. Epub 2011 Oct 29.

本文引用的文献

1
Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial.在细胞毒化疗失败后，转移性胰腺神经内分泌肿瘤患者的每日口服依维莫司治疗：一项 II 期试验。
J Clin Oncol. 2010 Jan 1;28(1):69-76. doi: 10.1200/JCO.2009.24.2669. Epub 2009 Nov 23.
2
Sunitinib paves the way for targeted therapies in neuroendocrine tumors.舒尼替尼为神经内分泌肿瘤的靶向治疗铺平了道路。
Target Oncol. 2009 Dec;4(4):253-4. doi: 10.1007/s11523-009-0130-0. Epub 2009 Nov 13.
3
Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group.奥曲肽长效注射剂（LAR）对转移性中肠神经内分泌肿瘤患者肿瘤生长控制效果的安慰剂对照、双盲、前瞻性、随机研究：PROMID研究组报告
J Clin Oncol. 2009 Oct 1;27(28):4656-63. doi: 10.1200/JCO.2009.22.8510. Epub 2009 Aug 24.
4
Temozolomide: a safe and effective treatment for malignant digestive endocrine tumors.替莫唑胺：一种治疗恶性消化内分泌肿瘤的安全有效的疗法。
Neuroendocrinology. 2009;90(1):67-72. doi: 10.1159/000225389. Epub 2009 Jun 11.
5
Surgical management of pancreatic endocrine tumors.胰腺内分泌肿瘤的外科治疗
Nat Rev Clin Oncol. 2009 Jul;6(7):419-28. doi: 10.1038/nrclinonc.2009.82. Epub 2009 Jun 9.
6
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: biotherapy.神经内分泌肿瘤治疗标准的ENETS共识指南：生物疗法
Neuroendocrinology. 2009;90(2):209-13. doi: 10.1159/000183751. Epub 2009 Aug 28.
7
Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.神经内分泌癌肝转移的经动脉栓塞、化疗栓塞和热消融介入治疗。
Eur J Radiol. 2009 Dec;72(3):517-28. doi: 10.1016/j.ejrad.2008.08.008. Epub 2008 Oct 1.
8
Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors.胃肠道神经内分泌肿瘤：胰腺内分泌肿瘤
Gastroenterology. 2008 Nov;135(5):1469-92. doi: 10.1053/j.gastro.2008.05.047. Epub 2008 Aug 12.
9
Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors.胰腺内分泌肿瘤：胰腺内分泌肿瘤的流行病学与预后
Endocr Relat Cancer. 2008 Jun;15(2):409-27. doi: 10.1677/ERC-07-0221.
10
Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors.沙利度胺用于转移性类癌和胰岛细胞瘤患者的II期研究。
Cancer Chemother Pharmacol. 2008 Apr;61(4):661-8. doi: 10.1007/s00280-007-0521-9. Epub 2007 Jun 23.

针对胰腺神经内分泌肿瘤转移的肝脏特异性疗法。

Liver-specific therapies for metastases of neuroendocrine pancreatic tumors.

作者信息

Fendrich Volker, Michl Patrick, Habbe Nils, Bartsch Detlef Klaus

机构信息

Volker Fendrich, Nils Habbe, Detlef Klaus Bartsch, Department of Surgery, Philipps-University, Marburg D-35043, Germany.

出版信息

World J Hepatol. 2010 Oct 27;2(10):367-73. doi: 10.4254/wjh.v2.i10.367.

DOI:10.4254/wjh.v2.i10.367
PMID:21160945
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2998945/
Abstract

The presence or development of liver metastases in patients with neuroendocrine pancreatic tumors is the most important prognostic factor. Liver resection, transplantation and many different therapeutic approaches are discussed in this special review.

摘要

神经内分泌胰腺肿瘤患者肝转移的存在或发展是最重要的预后因素。本专题综述讨论了肝切除、移植及许多不同的治疗方法。